Knight Therapeutics Inc. GUD
Free
No email, no account, no signup.
General analysis — not personal advice.
Bull
Bear
Want to follow Knight Therapeutics Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Exchange
TSX
Type
Biotech
Sector
Pharmaceuticals
Price & valuation
Last close
CAD 9.50
1 week
+2.6 %
3 months
+11.9 %
12 months
+48.0 %
From 52w high
-5.7 %
From 52w low
+65.2 %
We're already tracking Knight Therapeutics Inc. — here are the latest events we've registered
Recent News
- On August 6, 2026, Knight Therapeutics reported its second quarter 2026 financial results, delivering revenues of CAD 144.2 million, up 34% year-over-year. The company also raised its full-year 2026 revenue guidance to between CAD 540 million and CAD 560 million.
What Firelda Watch includes for Knight Therapeutics Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Knight Therapeutics Inc. will be delivered in the same format.
Want to follow Knight Therapeutics Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.